Denali Therapeutics (DNLI) EBT Margin (QoQ) (2018 - 2023)

Denali Therapeutics (DNLI) EBT Margin (QoQ) (2018 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Denali Therapeutics 3.90 Bn 3.90 Bn 3.51 Mn

Historic Data

Download Data
DateValue
Sep 30, 2023 -790,394.00
Jun 30, 2023 38,328.00
Mar 31, 2023 66,591.00
Dec 31, 2022 207,387.00
Sep 30, 2022 -294,873.00
Jun 30, 2022 5,203.00
Mar 31, 2022 -814.00
Dec 31, 2021 144,466.00
Sep 30, 2021 -119,592.00
Jun 30, 2021 47,953.00
Mar 31, 2021 -96,169.00
Dec 31, 2020 69,720.00
Sep 30, 2020 39,015.00
Jun 30, 2020 10.84 Mn
Mar 31, 2020 -10.58 Mn
Dec 31, 2019 -258,263.00
Sep 30, 2019 36,504.00
Jun 30, 2019 -50,391.00
Mar 31, 2019 -98,897.00
Dec 31, 2018 302,161.00